Trial Profile
Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate (Picato) in a Period of 8 Weeks.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2019
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 26 Mar 2014 New trial record